4.7 Article

Generation of a Perfusable 3D Lung Cancer Model by Digital Light Processing

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Recent Developments in 3D Bio-Printing and Its Biomedical Applications

Humira Assad et al.

Summary: The field of 3D bio-printing has been extensively used to improve the usability and performance of scaffolds filled with cells. Many tissues and organs have been produced via 3D bio-printing and can serve as building blocks for repair and regeneration, as well as in vitro models for pharmacokinetics and drug screening. The research focuses on novel biomaterials with quick cross-linking capabilities, a wider variety of acceptable 3D-printed materials, better printing resolution, and biomaterial compatibility.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids

Nathalie Bock et al.

Summary: 3D organoid model technologies and tunable hydrogel matrices provide innovative tools for cancer precision medicine, specifically for drug testing in breast cancer by mimicking key characteristics of the disease's extracellular matrix.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures

Samantha Sabetta et al.

Summary: Three-dimensional cell culture methods, particularly the 3D multicellular tumor spheroids model, enhance the predictive relevance of in vitro tumor models by better resembling tumor complexity and drug resistance. Recent advancements in 3D printing techniques and suitable biomaterials have provided new opportunities for developing reproducible and high-throughput 3D tissue cultures. In this study, the comparison of DU145 and U87 cancer cells cultured in the 3D spheroids model and the 3D bioprinting model showed that bioprinted cells demonstrated similar drug resistance to spheroids, suggesting a potential mechanism of drug resistance. The 3D bioprinted model utilizing alginate/gelatin hydrogel was proven to be a feasible, reproducible, and scalable model for drug screening when spheroid growth is required.

PHARMACEUTICS (2023)

Review Multidisciplinary Sciences

Stereolithography apparatus and digital light processing-based 3D bioprinting for tissue fabrication

Wanlu Li et al.

Summary: Three-dimensional (3D) bioprinting, particularly using stereolithography apparatus (SLA) and digital light processing (DLP)-based vat-polymerization techniques, is a promising approach in biomedical research for producing high-resolution and architecturally sophisticated structures. This review provides an overview of the factors that affect SLA- and DLP-based 3D bioprinting processes, as well as the advances in bioinks used in these techniques. Additionally, the biomedical applications of SLA and DLP-based bioprinting, primarily in regenerative medicine and tissue modeling engineering, are discussed.

ISCIENCE (2023)

Review Medicine, Research & Experimental

Poor Translatability of Biomedical Research Using Animals - A Narrative Review

Lindsay J. Marshall et al.

Summary: The failure rate for the translation of drugs from animal testing to human treatments remains high at over 92%. Many failures occur due to unexpected safety issues or lack of efficacy. However, the use of innovative tools, like organs-on-chips, in preclinical drug testing has shown promising results in predicting safety events and efficacy. This article reviews disease areas where animal models have failed and suggests the application of more human-relevant approaches to address this issue.

ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2023)

Article Multidisciplinary Sciences

High cell density and high-resolution 3D bioprinting for fabricating vascularized tissues

Shangting You et al.

Summary: Three-dimensional bioprinting techniques are widely used for fabricating 3D-engineered tissues, but face challenges in maintaining high cell density, cell viability, and fabrication resolution simultaneously. A novel approach using iodixanol in bioink was developed to reduce light scattering and improve fabrication resolution. Tissues with high cell density and fine vascular networks were successfully fabricated, and showed viability and endothelialization after 14 days of culture in a perfusion system.

SCIENCE ADVANCES (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Biochemistry & Molecular Biology

Bioprinted Cancer Model of Neuroblastoma in a Renal Microenvironment as an Efficiently Applicable Drug Testing Platform

Dongwei Wu et al.

Summary: This study developed a neuroblastoma three-dimensional model based on a human-derived environment, which can be used to test the cytotoxicity and tumor selectivity of new anticancer drugs. Compared to two-dimensional culture, this model has advantages in the width of the therapeutic window, demonstrating the value of studying anticancer drugs in human three-dimensional models.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Development and evaluation of a multicomponent bioink consisting of alginate, gelatin, diethylaminoethyl cellulose and collagen peptide for 3D bioprinting of tissue construct for drug screening application

Rency Geevarghese et al.

Summary: Three-dimensional bioprinting technology has advanced in the field of tissue engineering and drug screening, but there is limited research on its application in developing tumor models. In this study, a multicomponent bioink was developed and used to generate a 3D bioprinted tumor model for drug screening, demonstrating its efficacy.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Review Genetics & Heredity

Human organs-on-chips for disease modelling, drug development and personalized medicine

Donald E. Ingber

Summary: This Review discusses the types of single and multiple human organ-on-a-chip (organ chip) microfluidic devices and their diverse applications for disease modeling, drug development, and personalized medicine. It also addresses the challenges that must be overcome for organ chips to reach their full potential and discusses recent advances in the field.

NATURE REVIEWS GENETICS (2022)

Article Engineering, Biomedical

3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing

Daniel Nothdurfter et al.

Summary: This paper presents a novel 3D printed neuroblastoma-tumor-environment model and a biofabrication platform suitable for studying tumor angiogenesis and metastasis.

BIOFABRICATION (2022)

Review Engineering, Biomedical

Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application

MoonSun Jung et al.

Summary: The tumor microenvironment is complex and difficult to replicate using traditional 2D cell culture models. The development of 3D tumor models through bioprinting technology has the potential to bridge the gap between in vitro and in vivo, offering accurate representation of the tumor microenvironment.

ADVANCED HEALTHCARE MATERIALS (2022)

Article Biochemistry & Molecular Biology

Evaluating the Suitability of 3D Bioprinted Samples for Experimental Radiotherapy: A Pilot Study

Munir A. Al-Zeer et al.

Summary: Radiotherapy is crucial in the treatment of lung cancer, but standardized samples are needed to evaluate new therapeutic approaches. 3D bioprinting techniques provide a sophisticated solution to this challenge. A pilot project using 3D printed standardized samples evaluated the effectiveness of radiotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening

Aragaw Gebeyehu et al.

Summary: A series of stable bioinks based on xeno-free and tunable hydrogel system have been developed for extrusion bioprinting and tumor microenvironment simulation. These bioinks showed excellent rheological properties and cell viability, making them suitable for extrusion bioprinting applications.

SCIENTIFIC REPORTS (2021)

Article Engineering, Biomedical

3D Liver Tissue Model with Branched Vascular Networks by Multimaterial Bioprinting

Xin Liu et al.

Summary: This study presents a methodology for fabricating soft vascularized tissue at centimeter scale using multimaterial bioprinting with a customized multistage-temperature-control printer. The printed constructs can support 3D capillary networks to mimic mature and functional liver tissue, and also enable direct surgical anastomosis of blood vessels with the printed pressure-bearing layer. This versatile platform allows for optimal cellularization in engineered tissues through the replication of vasculature networks.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Biochemistry & Molecular Biology

3D Bioprinting of Human Tissues: Biofabrication, Bioinks, and Bioreactors

Jianhua Zhang et al.

Summary: Three-dimensional (3D) bioprinting is a promising approach for tissue engineering, allowing precise placement of cells and biomaterials to mimic complex microstructures of biological tissues. Bioprinted tissues can benefit from exposure to fluid mechanical cues provided by bioreactor systems, aiding in tissue development and function.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemical Research Methods

3D bioprinting: novel approaches for engineering complex human tissue equivalents and drug testing

Judith Hagenbuchner et al.

Summary: Conventional drug development methods have significant drawbacks, while 3D bioprinting technology offers new possibilities for drug testing.

3D BIOPRINTING (2021)

Article Immunology

Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma

Meiyu Chen et al.

Summary: The combination therapy of Gem and T alpha 1 effectively inhibits the progression of NNKTL both in vitro and in vivo, with suppression of tumor growth, promotion of apoptosis and autophagy, and inhibition of the PI3K/AKT/mTOR pathway.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Virology

Bioprinted Multi-Cell Type Lung Model for the Study of Viral Inhibitors

Johanna Berg et al.

Summary: This study describes the construction of a human lung model using bioprinting technology, which supports the study of pulmonary pathogenic biology and the development of new therapeutics. The model demonstrated the ability to generate an immune response and restrict the replication of a seasonal IAV strain in antiviral assays.

VIRUSES-BASEL (2021)

Review Oncology

Molecular therapeutic targets in non-small cell lung cancer

Kamya Sankar et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2020)

Article Chemistry, Analytical

3D-Printed Bubble-Free Perfusion Cartridge System for Live-Cell Imaging

Daigo Terutsuki et al.

SENSORS (2020)

Review Oncology

The Resistance Mechanisms of Lung Cancer Immunotherapy

Fen Wang et al.

FRONTIERS IN ONCOLOGY (2020)

Article Engineering, Biomedical

The bioprinting roadmap

Wei Sun et al.

BIOFABRICATION (2020)

Article Mathematical & Computational Biology

Estimation of clinical trial success rates and related parameters

Chi Heem Wong et al.

BIOSTATISTICS (2019)

Review Oncology

Emerging therapies for non-small cell lung cancer

Chao Zhang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Medicine, General & Internal

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review

Kathryn C. Arbour et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Review Pharmacology & Pharmacy

3D organ models-Revolution in pharmacological research?

Marie Weinhart et al.

PHARMACOLOGICAL RESEARCH (2019)

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

Review Engineering, Biomedical

3D Bioprinting for Organ Regeneration

Haitao Cui et al.

ADVANCED HEALTHCARE MATERIALS (2017)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Article Anatomy & Morphology

Tissue Vascularization Through 3D Printing: Will Technology Bring Us Flow?

S. J. Paulsen et al.

DEVELOPMENTAL DYNAMICS (2015)

Article Biochemical Research Methods

A microfluidic bubble trap and oscillator

Janick D. Stucki et al.

LAB ON A CHIP (2015)

Article Oncology

Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer

Yoshinori Imamura et al.

ONCOLOGY REPORTS (2015)

Article Cell Biology

Building Vascular Networks

Hojae Bae et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Article Biochemical Research Methods

Activity of Anticancer Agents in a Three-Dimensional Cell Culture Model

Victor Sanjit Nirmalanandhan et al.

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2010)

Review Pharmacology & Pharmacy

Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors

Romano Danesi et al.

PHARMACOGENOMICS (2009)

Article Chemistry, Physical

Modular tissue engineering: engineering biological tissues from the bottom up

Jason W. Nichol et al.

SOFT MATTER (2009)

Article Cell & Tissue Engineering

Vascularization-The Conduit to Viable Engineered Tissues

Tamar Kaully et al.

TISSUE ENGINEERING PART B-REVIEWS (2009)

Article Biochemistry & Molecular Biology

Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis

EB Affar et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)